Diabetes is a group of metabolic conditions that share one core feature: blood sugar levels stay too high because the body either cannot make enough insulin, cannot use insulin properly, or both. Insulin, a hormone produced by specialized cells in the pancreas, acts as the key that lets sugar move from your bloodstream into your cells for energy. When that system breaks down, glucose accumulates in the blood and gradually damages blood vessels, nerves, and organs. The disease comes in several distinct forms with different causes, and its symptoms can range from barely noticeable to life-threatening.
What Insulin Actually Does
Understanding diabetes starts with understanding insulin. After you eat, your blood sugar rises. In response, beta cells clustered in small structures called the islets of Langerhans inside the pancreas release insulin into the bloodstream. That insulin does several things at once: it tells your liver to stop releasing stored glucose, it signals your muscles and fat tissue to absorb sugar from the blood, and it suppresses the breakdown of fat so that glucose remains the primary fuel source.1PubMed. Insulin: The master regulator of glucose metabolism Insulin also promotes the storage of glucose in the liver and muscles for later use, which is part of why the hormone is sometimes described as working along an “anabolic” or building-up pathway.2PubMed Central. Role of Insulin in Health and Disease: An Update When insulin is absent or cells stop responding to it, blood sugar climbs and stays elevated. That chronic elevation is what doctors call diabetes.
Type 1 Diabetes
Type 1 diabetes is an autoimmune disease. The immune system mistakenly identifies the insulin-producing beta cells in the pancreas as foreign and destroys them.3PubMed Central. The beta cell-immune cell interface in type 1 diabetes Once enough beta cells are gone, the pancreas can no longer produce meaningful amounts of insulin, and the person needs daily insulin injections or an insulin pump to survive. This destruction typically begins well before symptoms appear; by the time blood sugar rises noticeably, the majority of beta cells have already been lost.
Type 1 is most often diagnosed in children and young adults, though it can appear at any age. Its triggers are not fully understood, but the process involves a combination of genetic susceptibility and environmental factors such as viral infections. It accounts for a relatively small share of all diabetes cases, roughly five to ten percent, yet it remains one of the most common chronic diseases of childhood.
Type 2 Diabetes
Type 2 diabetes is far more common and develops through a different mechanism. It begins with insulin resistance: your cells, especially in muscle, liver, and fat tissue, gradually stop responding normally to insulin. The pancreas tries to compensate by making more, but over time the beta cells wear out and insulin production falls.4PubMed Central. Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress The progression follows a characteristic pattern: first you lose the rapid burst of insulin your body normally releases right after eating, then you gradually lose the ability to secrete enough insulin overall, and eventually baseline insulin output drops so low that injected insulin becomes necessary.5PubMed. beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms
Excess body fat, particularly around the abdomen and internal organs, plays a central role. Visceral fat accumulation leads to excess lipid buildup in the liver and muscles, which directly impairs insulin signaling at the cellular level. Visceral fat tissue is also prone to chronic low-grade inflammation, and the inflammatory signals it produces further blunt the body’s response to insulin.6PubMed Central. What causes the insulin resistance underlying obesity? Inflammation, lipid overload, and stress inside cells all contribute to insulin resistance across multiple tissues simultaneously.7PubMed Central. Mechanisms of muscle insulin resistance and the cross-talk with liver and adipose tissue
Gestational Diabetes
Gestational diabetes develops during pregnancy and usually resolves after delivery. During a normal pregnancy, the body naturally becomes more insulin-resistant to ensure that enough glucose reaches the growing fetus. This is a healthy adaptation. But when a woman’s beta cells cannot keep up with the increased demand, blood sugar rises beyond the normal range.8PubMed Central. The Pathophysiology of Gestational Diabetes Mellitus Hormonal and inflammatory changes in the placenta can aggravate the problem, affecting blood flow and nutrient delivery between mother and baby.9PubMed Central. The Placental Role in Gestational Diabetes Mellitus: A Molecular Perspective
Gestational diabetes matters beyond the pregnancy itself. Women who develop it face a substantially higher lifetime risk of being diagnosed with type 2 diabetes later. Their children may also face an elevated risk of obesity and metabolic problems. Screening typically happens between weeks 24 and 28 of pregnancy, but women with strong risk factors are sometimes tested earlier.
Less Common Forms
Not all diabetes fits neatly into the type 1 or type 2 categories. Monogenic diabetes is caused by a mutation in a single gene and accounts for roughly one to five percent of all diabetes cases.10PubMed Central. Monogenic diabetes The most common variety, maturity-onset diabetes of the young (MODY), typically appears before age 25, runs in families with a clear parent-to-child inheritance pattern, and is not driven by insulin resistance or autoimmunity. At least 14 subtypes of MODY have been identified, each linked to a different gene. Some subtypes produce such mild blood sugar elevation that treatment beyond diet is rarely needed, while others cause progressive beta-cell failure and carry complication risks similar to type 2 diabetes.11PubMed Central. Monogenic diabetes: An evidence-based clinical approach
Neonatal diabetes, another monogenic form, appears within the first six months of life. About half of cases are permanent, while others go into remission and may or may not return later. Some forms of neonatal diabetes respond well to a type of oral medication called sulfonylureas, which can replace insulin injections entirely, making genetic testing especially important for these families.11PubMed Central. Monogenic diabetes: An evidence-based clinical approach
There is also latent autoimmune diabetes of adults, sometimes called LADA, which shares features with both type 1 and type 2. People with LADA are typically diagnosed as adults and may initially look like they have type 2 diabetes, but they carry autoimmune markers, particularly antibodies against an enzyme called glutamic acid decarboxylase, and they gradually lose beta-cell function over months to years.12PubMed Central. Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus Recognizing LADA matters because these patients tend to need insulin sooner than typical type 2 patients and respond differently to standard oral medications.
Recognizing the Symptoms
The classic symptoms of diabetes stem directly from high blood sugar. When glucose builds up in the blood faster than the kidneys can reabsorb it, the excess spills into the urine, pulling water along with it. That produces frequent urination and, as a result, persistent thirst. Because your cells are starved of their primary fuel, you may feel constantly hungry even as you lose weight (this is more dramatic in type 1 than type 2). Fatigue is one of the most common complaints across all forms of diabetes and is linked to the metabolic disruption itself as well as to related complications like nerve damage and kidney strain.13ScienceDirect. Chapter 13 – Fatigue in diabetes
Other warning signs include blurred vision caused by fluid shifts in the lens of the eye, slow-healing cuts or sores, and frequent infections. Numbness or tingling in the hands and feet can appear when blood sugar has been elevated for long enough to start damaging small nerves. Type 1 diabetes tends to announce itself suddenly, with severe symptoms developing over days or weeks. Type 2 often creeps in so gradually that many people are diagnosed only after routine blood work or when a complication surfaces.
Acute Emergencies
Two dangerous situations can arise when blood sugar spirals out of control. Diabetic ketoacidosis, or DKA, occurs when insulin levels are so low that the body shifts entirely to burning fat for fuel. This process floods the blood with acidic molecules called ketones, dropping blood pH to dangerous levels. DKA can cause nausea, vomiting, abdominal pain, fruity-smelling breath, confusion, and, if untreated, coma and death. It is most common in type 1 diabetes but can also occur in type 2 under severe stress or illness.14PubMed Central. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state
Hyperosmolar hyperglycemic state, or HHS, is more typical of type 2 diabetes. Blood sugar climbs to extreme levels and severe dehydration sets in, but significant ketone production does not occur. HHS tends to develop more slowly than DKA but carries a high mortality rate, particularly in older adults.15Journal of Education, Health and Sport. Hyperosmolar hyperglycemic syndrome: A comprehensive review of clinical presentation, diagnosis, and treatment strategies in hyperglycemic crises Both conditions are medical emergencies requiring hospitalization and intravenous fluids.
Long-Term Damage
Chronically elevated blood sugar injures blood vessels throughout the body, and the pattern of that damage divides roughly into small-vessel and large-vessel complications. Small-vessel damage drives the three conditions most closely associated with diabetes: kidney disease, eye damage that can lead to blindness, and nerve damage that, in severe cases, leads to foot ulcers and amputations. Large-vessel damage accelerates atherosclerosis, increasing the risk of heart attacks, strokes, and peripheral artery disease. Metabolic disruption from diabetes can affect the heart, kidneys, brain, and other vital organs over time, making prevention of vascular complications one of the central goals of diabetes management.
The severity of these complications correlates with how well blood sugar is controlled and for how long it has been elevated. Other risk factors such as high blood pressure, high cholesterol, and smoking compound the damage. This is why diabetes management involves far more than glucose-lowering drugs; it usually includes blood pressure control, cholesterol management, and regular screening for early signs of eye, kidney, and nerve disease.
How Diabetes Is Diagnosed
Diagnosis relies on blood tests that measure glucose in different ways. A fasting blood glucose test checks your level after at least eight hours without eating. An oral glucose tolerance test measures how your blood sugar responds to a standardized sugar drink over two hours. Studies comparing these methods found that fasting glucose and the two-hour glucose test were superior to HbA1c for detecting diabetes when retinopathy was used as the reference standard.16Diabetes Care. Comparison of Fasting and 2-Hour Glucose and HbA1c Levels for Diagnosing Diabetes: Diagnostic criteria and performance revisited
HbA1c, which reflects your average blood sugar over the previous two to three months, is widely used because it does not require fasting and is convenient. However, it has real limitations. Conditions that affect red blood cells, including sickle cell trait, iron deficiency, and certain anemias, can skew the result. There are also documented differences across racial and ethnic groups in the relationship between HbA1c and actual blood sugar levels, meaning the same HbA1c number does not necessarily reflect the same degree of glucose control in every person.17The Journal of Clinical Endocrinology & Metabolism. Racial and Ethnic Differences in the Relationship between HbA1c and Blood Glucose: Implications for the Diagnosis of Diabetes For this reason, many clinicians use HbA1c alongside glucose-based tests rather than relying on it alone, especially in populations where misclassification risk is higher.
Risk Factors and Whether Prevention Is Possible
Type 1 diabetes cannot currently be prevented, though research into early immune-modifying treatments is active. For type 2 diabetes, genetics and lifestyle both contribute. Having close family members with type 2 raises your risk, and dozens of gene variants have been linked to the disease, but lifestyle choices play a powerful modifying role. Gene-lifestyle interaction studies suggest that genetic susceptibility to obesity and type 2 diabetes can be partially or even fully offset by healthy habits or lifestyle changes.18PubMed. Lifestyle and genetics in obesity and type 2 diabetes Specific examples include interactions between certain genetic variants and dietary fiber intake, physical activity levels, and weight management, all influencing whether the genetic risk actually translates into disease.19PubMed Central. Gene-lifestyle interaction on risk of type 2 diabetes: A systematic review
Sleep is a risk factor that gets less attention than diet and exercise. Laboratory studies have shown that reducing either the amount or the quality of sleep decreases insulin sensitivity and impairs glucose tolerance.20PubMed Central. Metabolic effects of sleep disruption, links to obesity and diabetes Chronic sleep deprivation, shift work, and sleep disorders like obstructive sleep apnea have all been associated with higher diabetes risk, and improving sleep is increasingly recognized as a meaningful lever for metabolic health.
The Gut Microbiome Connection
One of the more surprising threads in diabetes research over the past decade involves the bacteria living in your gut. People with obesity tend to have different ratios of bacterial groups compared with leaner individuals, with a higher proportion of certain phyla and a lower proportion of others. This imbalance appears to increase the permeability of the gut lining, allowing bacterial fragments, especially a molecule called lipopolysaccharide, to leak into the bloodstream. Once there, these fragments trigger inflammatory pathways that impair insulin signaling in a way that mirrors the cellular mechanisms seen in insulin resistance more broadly.21PubMed Central. The role of gut microbiota on insulin resistance Reduced production of certain beneficial compounds by gut bacteria, particularly short-chain fatty acids, may further worsen insulin sensitivity.22PubMed. Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance
This area of research is still young, and no microbiome-based treatment has become standard for diabetes. But it helps explain why factors like diet quality, antibiotic use, and fiber intake can influence metabolic health in ways that go beyond simple calorie counting. The gut, it turns out, is not a passive bystander in how your body handles sugar.
The Thrifty Genotype Idea
A question that has lingered since the 1960s is why genes that predispose people to type 2 diabetes are so common in the first place. The thrifty genotype hypothesis, first proposed in 1962, offers one explanation: throughout most of human history, famine was a recurring threat, and individuals whose bodies were especially efficient at storing fat during times of plenty had a survival advantage. Genes that promoted rapid fat storage would have been favored by natural selection.23PubMed. Overview of the thrifty genotype hypothesis The hypothesis argues that in modern environments where calorie-dense food is constantly available, those same fat-storing genes now contribute to obesity and diabetes rather than protecting against starvation.24Evolution, Medicine, and Public Health. Integrating the Thrifty Genotype and Evolutionary Mismatch Hypotheses to understand variation in cardiometabolic disease risk
The idea finds some support in populations that experienced rapid transitions from traditional to modern lifestyles and then saw explosive increases in diabetes rates.25PubMed. The thrifty genotype in type 2 diabetes: an unfinished symphony moving to its finale? Critics argue that the hypothesis is difficult to test rigorously and may oversimplify a more complicated picture involving many genes and environmental pressures. Still, it remains one of the most widely discussed frameworks for thinking about why type 2 diabetes is so prevalent across diverse human populations. Whether or not the specific evolutionary story holds up, the mismatch between our biology and our food environment is hard to dispute.
How Insulin Went from Discovery to Lifeline
Before insulin was isolated in 1921, a diabetes diagnosis, particularly what we now call type 1, was essentially a death sentence. The only treatment available was severe caloric restriction, which could extend life by months but not much more. The discovery of insulin by Frederick Banting and his colleagues transformed the prognosis almost overnight. Children who had been wasting away were revived within days of their first injections.26PubMed Central. The Discovery of Insulin: An Important Milestone in the History of Medicine Descriptions of diabetes itself, however, go back thousands of years. Ancient Egyptian, Indian, and Chinese medical texts all recorded the disease’s hallmark symptoms, and physicians in those traditions had observed the link between sweet-tasting urine and wasting illness long before anyone understood the mechanism.
That history helps frame how far treatment has come in a remarkably short time. Today the toolkit includes rapid-acting and long-acting insulin analogs, continuous glucose monitors, automated insulin pumps, and a growing list of medications that target different aspects of glucose metabolism. Yet even with these tools, the global burden of diabetes continues to rise, driven largely by increases in type 2 linked to changing diets, declining physical activity, and aging populations. The science of diabetes is mature in many ways, but the epidemic it describes remains a work in progress.